<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(10)</volume><submitter>Wang F</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Psoriasis has been linked to dyslipidemia. However, the magnitude of the association between psoriasis and serum apolipoproteins A1 and B remains unclear.&lt;h4>Methods&lt;/h4>We systematically searched PubMed, Embase, and Cochrane Library databases for eligible studies published before August 10, 2023. Data were pooled using Stata software. We adopted a random-effects model for the meta-analysis. Additionally, we conducted subgroup analyses of the studies according to the psoriasis type and matched body mass index (BMI).&lt;h4>Results&lt;/h4>Seventeen studies involving 2467 participants were included. Psoriasis was associated with decreased serum apolipoprotein A1 (weighted mean difference [WMD] = -9.05, &lt;i>P&lt;/i> &lt; 0.001) and increased serum apolipoprotein B (WMD = 11.68, &lt;i>P&lt;/i> </pubmed_abstract><journal>Heliyon</journal><pagination>e21168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10622706</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association between psoriasis and serum apolipoprotein A1 and B: A systematic review and meta-analysis.</pubmed_title><pmcid>PMC10622706</pmcid><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Mu J</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Kong X</pubmed_authors><pubmed_authors>Ye J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between psoriasis and serum apolipoprotein A1 and B: A systematic review and meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Psoriasis has been linked to dyslipidemia. However, the magnitude of the association between psoriasis and serum apolipoproteins A1 and B remains unclear.&lt;h4>Methods&lt;/h4>We systematically searched PubMed, Embase, and Cochrane Library databases for eligible studies published before August 10, 2023. Data were pooled using Stata software. We adopted a random-effects model for the meta-analysis. Additionally, we conducted subgroup analyses of the studies according to the psoriasis type and matched body mass index (BMI).&lt;h4>Results&lt;/h4>Seventeen studies involving 2467 participants were included. Psoriasis was associated with decreased serum apolipoprotein A1 (weighted mean difference [WMD] = -9.05, &lt;i>P&lt;/i> &lt; 0.001) and increased serum apolipoprotein B (WMD = 11.68, &lt;i>P&lt;/i> </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-04T10:32:57.511Z</modification><creation>2025-04-04T10:32:57.511Z</creation></dates><accession>S-EPMC10622706</accession><cross_references><pubmed>37928384</pubmed><doi>10.1016/j.heliyon.2023.e21168</doi></cross_references></HashMap>